Sham Microinjector clinical trials

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

This study is testing a new treatment called bel-sar for a type of eye cancer called choroidal melanoma, or for unclear spots in the eye that might become cancer. Doctors want to see if bel-sar is safe and works better than a dummy treatment to stop these eye problems from getting worse.